Holen Sie sich die Stockscreener-App
13.00
2.69%
0.34
Handel nachbörslich:
13.08
0.08
+0.62%
Schlusskurs vom Vortag:
$12.66
Offen:
$12.7
24-Stunden-Volumen:
2.36M
Relative Volume:
1.26
Marktkapitalisierung:
$1.98B
Einnahmen:
$177.28M
Nettoeinkommen (Verlust:
$-195.24M
KGV:
-9.7015
EPS:
-1.34
Netto-Cashflow:
$-114.54M
1W Leistung:
+11.21%
1M Leistung:
+9.98%
6M Leistung:
+52.58%
1J Leistung:
+185.09%
1-Tages-Spanne:
$12.66
$13.37
1-Wochen-Bereich:
$11.40
$13.37
52-Wochen-Spanne:
$3.981
$13.37
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
13.00 | 1.93B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Adaptive Biotechnologies Reaches Analyst Target Price - Nasdaq
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Just Reported And Analysts Have Been Lifting Their Price Targets - ca.finance.yahoo.com
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences - 富途牛牛
Adaptive Biotechnologies’ Earnings Call Highlights Growth - The Globe and Mail
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $14 to $15 - 富途牛牛
Adaptive Biotechnologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Over - GuruFocus
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Overweight Rating | ADPT Stock News - GuruFocus
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday - Yahoo Finance
JP Morgan Maintains Overweight on Adaptive, Raises PT to $14 from $10 - AInvest
Adaptive Biotechnologies (ADPT) Rating Update: TD Cowen Raises Price Target | ADPT Stock News - GuruFocus
TD Cowen Keeps Buy Rating, Raises PT to $15 on Adaptive Biotechnologies - AInvest
Piper Sandler Raises Price Target for ADPT to $15.00 | ADPT Stock News - GuruFocus
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $11 to $15 - 富途牛牛
Adaptive Biotechnologies stock hits 52-week high at $12.50 By Investing.com - Investing.com India
Adaptive Biotechnologies stock hits 52-week high at $12.50 - Investing.com
Adaptive Biotechnologies (ADPT) Price Target Increased by JPMorg - GuruFocus
Adaptive Biotechnologies Exceeds Q2 Expectations Despite LossNews and Statistics - IndexBox
Adaptive Biotechnologies: Q2 Earnings Snapshot - New Haven Register
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... By GuruFocus - Investing.com Canada
Advanced analytics toolkit walkthrough for Adaptive Biotechnologies CorporationFree Swing Trading Entry Point Signals - Newser
Adaptive Biotechnologies Q2 2025 slides: MRD business achieves profitability milestone - Investing.com Nigeria
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings - Yahoo Finance
Adaptive Biotechnologies’ MRD Business Powers Past Expectations - Finimize
Adaptive Biotechnologies (ADPT) Surpasses Revenue Expectations i - GuruFocus
Earnings call transcript: Adaptive Biotechnologies beats Q2 2025 forecasts By Investing.com - Investing.com Australia
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Adaptive Biotechnologies beats Q2 2025 forecasts - Investing.com
Adaptive Biotechnologies soars 8.5% as MRD business achieves profitability - Investing.com
Adaptive Biotechnologies soars 8.5% as MRD business achieves profitability By Investing.com - Investing.com UK
Adaptive Biotechnologies earnings beat by $0.07, revenue topped estimates - Investing.com South Africa
Adaptive Biotechnologies Corp SEC 10-Q Report - TradingView
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results - TradingView
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesFree Consistent Gain Investment Strategies - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationFundamental Analysis for Value Stock Selection - Newser
Adaptive Biotechnologies Corp (ADPT) Q2 2025: Everything You Nee - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Craig-Hallum Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating - 富途牛牛
Using AI based signals to follow Adaptive Biotechnologies CorporationCapital Growth Plan for New Investors - Newser
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):